Medical Software Market Report 2026

The medical software market size has grown rapidly in recent years. It will grow from $67.54 billion in 2025 to $77.35 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to digitization of healthcare records, government initiatives for health IT adoption, rising hospital patient volumes, need for efficient billing and coding systems, growth of private healthcare facilities.

The medical software market size is expected to see rapid growth in the next few years. It will grow to $122.89 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expansion of telehealth services, increasing healthcare data complexity, demand for cost-efficient healthcare delivery, rising focus on patient-centric care models, adoption of cloud-based medical software. Major trends in the forecast period include integrated patient data management platforms, growing adoption of telemedicine software, workflow automation in healthcare administration, rising demand for interoperable software systems, focus on regulatory-compliant medical software.

The increasing aging population and prevalence of chronic diseases are anticipated to drive the growth of the medical software market in the coming years. The aging population refers to the growing proportion of older individuals within society, while chronic diseases are persistent conditions that require ongoing monitoring and management. Factors such as longer life expectancy, sedentary lifestyles, poor dietary habits, smoking, and greater exposure to long-term health risks are contributing to the rise of both the aging population and chronic diseases. The medical software market caters to this trend by facilitating remote monitoring, personalized treatment planning, continuous disease management, and data-driven decision-making for older adults living with chronic conditions. For example, in October 2023, according to the United Nations Department of Economic and Social Affairs (UN DESA), a U.S.-based intergovernmental organization, the global population aged 65 years and older reached 0.8 billion in 2023 and is projected to grow to 1.6 billion by 2050, highlighting the rapid expansion of the aging population that increasingly requires chronic-care digital solutions. Furthermore, in April 2024, according to Allergy UK, a U.K.-based national charity, over 0.021 billion people in the United Kingdom were affected by allergies, one of the region’s most prevalent chronic health conditions, with projections suggesting that by 2026, half of Europe’s population will experience at least one chronic allergic condition. Consequently, the growth of the aging population and chronic diseases is fueling the expansion of the medical software market.

Major companies in the medical software market are prioritizing the development of advanced technological solutions, such as smart health assistants, to reduce the workload of healthcare staff and enhance operational efficiency by leveraging AI to optimize clinical and administrative processes. Smart health assistants are AI-powered digital tools designed to help users manage their health by providing services like appointment management and medication reminders. For example, in October 2024, Microsoft Corporation, a US-based technology company, introduced the Health-Care AI Suite to help healthcare organizations develop AI applications more effectively. The suite includes tools such as medical imaging models, AI agents, and automated documentation solutions, aimed at reducing clinician workloads and increasing productivity. The Health-Care AI Suite is important because it enables health systems to streamline administrative tasks, improve data accuracy, and ensure efficient access to clinical information, directly addressing common industry challenges such as burnout and documentation inefficiencies.

In April 2024, GE HealthCare Technologies Inc., a US-based medical technology company, acquired MIM Software for an undisclosed amount. Through this acquisition, GE HealthCare Technologies aims to strengthen its support for provider needs by offering established solutions that simplify, automate, and streamline critical tasks, thereby enhancing workflows. MIM Software is a US-based medical software company that provides solutions for radiation oncology, nuclear medicine, medical radiology, and related areas.

Major companies operating in the medical software market are McKesson Corporation, OptumHealth, Siemens Healthineers, Koninklijke Philips NV, GE HealthCare Technologies, Henry Schein Inc., Quest Diagnostics Incorporated, Cerner Corporation, Epic Systems Corporation, Athenahealth Inc., CompuGroup Medical SE & Co KGaA, eClinicalWorks, Allscripts Healthcare Solutions Inc., Greenway Health LLC, Computer Programs and Systems Inc., Sunquest Information Systems Inc., Merge Healthcare Incorporated, NextGen Healthcare Inc., First Databank Inc., CureMD Healthcare, Practice Fusion Inc., Updox LLC.

North America was the largest region in the medical software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the medical software market by increasing costs related to imported IT infrastructure, server hardware, and integrated software components used in healthcare facilities. The impact is more pronounced across EHR systems, telemedicine platforms, and billing software, particularly in regions dependent on imported technology such as Asia-Pacific and parts of Latin America. Higher implementation costs have slightly delayed software upgrades for small clinics and ambulatory centers. However, tariffs have also encouraged local software development, regional partnerships, and cloud-based deployment models, supporting long-term market adaptability.

The medical software market research report is one of a series of new reports that provides medical software market statistics, including medical software industry global market size, regional shares, competitors with a medical software market share, detailed medical software market segments, market trends and opportunities, and any further data you may need to thrive in the medical software industry. This medical software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical software encompasses specialized applications and platforms created to support healthcare professionals in a variety of tasks associated with patient care within medical facilities. It helps streamline the management of patient records, diagnosis, treatment planning, and healthcare administration.

The primary categories of medical software include electronic health records (EHR), medical practice management software, telemedicine software, medical billing and coding software, clinical decision support systems (CDSS), and others. Electronic health records (EHR) are digital versions of patients' paper charts within a healthcare environment. They are utilized across hospitals, clinics, ambulatory care centers, and other settings by different end users, including providers, payers, and patients.

The medical software market includes revenues earned by entities by providing services, such as telehealth and telemedicine solutions, clinical decision support systems, health information exchange (HIE), and patient portals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.